Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F E Fox

Showing results (11-20 of 28) with videos related to

Pageof 3
Sort By:
Journal of Immunology (Baltimore, Md. : 1950)|September 22, 1999
Depressed IL-12-mediated signal transduction in T cells from patients with Sézary syndrome is associated with the absence of IL-12 receptor beta 2 mRNA and highly reduced levels of STAT4L C Showe, F E Fox, D Williams, et al.
Cancer Research|January 15, 1994
Transforming growth factor beta production and responsiveness in normal human melanocytes and melanoma cellsU Rodeck, A Bossler, U Graeven, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 1, 1987
Identification of a second T-cell antigen receptor in human and mouse by an anti-peptide gamma-chain-specific monoclonal antibodyC G Ioannides, K Itoh, F E Fox, et al.
International Archives of Allergy and Applied Immunology|January 1, 1988
Differential effects of human alpha and gamma interferon on mixed lymphocyte culture and on T-cell-mediated cytotoxicity. Inhibition of proliferation but not of IL-2 production by alpha interferonsF Chae, E Oleszak, F E Fox, et al.
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research|May 20, 1999
Retinoids synergize with interleukin-2 to augment IFN-gamma and interleukin-12 production by human peripheral blood mononuclear cellsF E Fox, M Kubin, M Cassin, et al.
Current Opinion in Oncology|April 29, 1998
Use of biological response modifiers in the treatment of cutaneous T-cell lymphomaA H Rook, E K Yoo, D J Grossman, et al.
Lymphokine and Cytokine Research|December 1, 1992
Transforming growth factor-beta inhibits human T-cell proliferation through multiple targetsF E Fox, R J Capocasale, H C Ford, et al.
Anticancer Research|July 1, 1989
Regulation of natural killer cytotoxicity by recombinant alpha interferons. Augmentation by IFN-alpha 7, an interferon similar to IFN-alpha JC D Platsoucas, F E Fox, E Oleszak, et al.
Leukemia Research|February 1, 1994
Richter's syndrome associated with loss of response to transforming growth factor-betaP C Nowell, J S Moore, F E Fox, et al.
Journal of Medical Ethics|December 23, 2009
"It's crucial they're treated as patients": ethical guidance and empirical evidence regarding treating doctor-patientsF E Fox, G J Taylor, M F Harris, et al.
Pageof 3

Showing results (11-20 of 28) with videos related to

Sort By:
Pageof 3
Journal of Immunology (Baltimore, Md. : 1950)|September 22, 1999
Depressed IL-12-mediated signal transduction in T cells from patients with Sézary syndrome is associated with the absence of IL-12 receptor beta 2 mRNA and highly reduced levels of STAT4L C Showe, F E Fox, D Williams, et al.
Cancer Research|January 15, 1994
Transforming growth factor beta production and responsiveness in normal human melanocytes and melanoma cellsU Rodeck, A Bossler, U Graeven, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 1, 1987
Identification of a second T-cell antigen receptor in human and mouse by an anti-peptide gamma-chain-specific monoclonal antibodyC G Ioannides, K Itoh, F E Fox, et al.
International Archives of Allergy and Applied Immunology|January 1, 1988
Differential effects of human alpha and gamma interferon on mixed lymphocyte culture and on T-cell-mediated cytotoxicity. Inhibition of proliferation but not of IL-2 production by alpha interferonsF Chae, E Oleszak, F E Fox, et al.
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research|May 20, 1999
Retinoids synergize with interleukin-2 to augment IFN-gamma and interleukin-12 production by human peripheral blood mononuclear cellsF E Fox, M Kubin, M Cassin, et al.
Current Opinion in Oncology|April 29, 1998
Use of biological response modifiers in the treatment of cutaneous T-cell lymphomaA H Rook, E K Yoo, D J Grossman, et al.
Lymphokine and Cytokine Research|December 1, 1992
Transforming growth factor-beta inhibits human T-cell proliferation through multiple targetsF E Fox, R J Capocasale, H C Ford, et al.
Anticancer Research|July 1, 1989
Regulation of natural killer cytotoxicity by recombinant alpha interferons. Augmentation by IFN-alpha 7, an interferon similar to IFN-alpha JC D Platsoucas, F E Fox, E Oleszak, et al.
Leukemia Research|February 1, 1994
Richter's syndrome associated with loss of response to transforming growth factor-betaP C Nowell, J S Moore, F E Fox, et al.
Journal of Medical Ethics|December 23, 2009
"It's crucial they're treated as patients": ethical guidance and empirical evidence regarding treating doctor-patientsF E Fox, G J Taylor, M F Harris, et al.
Pageof 3